The Evaluation of FeNO for Predicting Response to ICS in Subjects With Non-specific Respiratory Symptoms
NCT02294279
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
360
Enrollment
NETWORK
Sponsor class
Conditions
Asthma
Interventions
DRUG:
Qvar (100 mcg)
Sponsor
Research in Real-Life Ltd
Collaborators
[object Object]